FDA drug class
Lysosomal beta Glucuronidases list
Every FDA-approved prescription drug the FDA NDC directory tags with the Lysosomal beta Glucuronidase [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 1 single-ingredient drug in this class: vestronidase alfa.
Run it in Rivvi
Map Mepsevii and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Lysosomal beta Glucuronidases (1)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Vestronidase alfa | Mepsevii | Single ingredient | 1 | Not controlled |
FDA established pharmacologic class: Lysosomal beta Glucuronidase [EPC].
Questions
What drugs are Lysosomal beta Glucuronidases?
The FDA NDC directory lists 1 single-ingredient drug in this class: vestronidase alfa.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.